Supplement Claims Need Healthy Support, Not A Disease Cohort
This article was originally published in The Tan Sheet
Supplement firms should ensure supporting studies for structure/function claims avoid drug treatment findings, says NPA CEO Dan Fabricant. People with “higher-end-of-normal” range of health issues are critical to avoiding trial outcomes that attract FTC scrutiny.
You may also be interested in...
Seven of 10 CBD-containing supplement products tested in a lab did not contain the levels of CBD advertised on the label, says hemp, CBD and natural health product information publisher Remedy Reviews. Most products also were found to contain heavy metals.
P&G approach to advertising for SK-II skin care drove double-digit sales growth in new users and prompted a 27% increase in searches for the line. P&G has saved $1bn from cost-cutting in ad agencies and advertising implemented over past five years, says chief brand officer Marc Pritchard.
HBW Market News: DSM Taps Co-CEOs, Bayer Consumer Ex-US Changes Ad Firm, Recover 180° Sponsors Champ, More
Former PepsiCo exec Beraud's Sh’nnong Beverage launches Ma Functional Iced Teas with CBD+ Natural Botanicals; Chobani expands beyond yogurt with oat-based products; Recover 180° sponsors boxer Deontay Wilder; Mighty Self Balance CBD targets inflammation; Oki CBD drinks reach Florida; Bayer consumer taps ad firm MullenLowe; and Royal DSM will have co-CEOs when CEO Sijbesma leaves.